384 related articles for article (PubMed ID: 30610927)
1. Neuroinflammation in mild cognitive impairment and Alzheimer's disease: A meta-analysis.
Bradburn S; Murgatroyd C; Ray N
Ageing Res Rev; 2019 Mar; 50():1-8. PubMed ID: 30610927
[TBL] [Abstract][Full Text] [Related]
2. Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort?
Fan Z; Harold D; Pasqualetti G; Williams J; Brooks DJ; Edison P
J Nucl Med; 2015 May; 56(5):707-13. PubMed ID: 25840980
[TBL] [Abstract][Full Text] [Related]
3. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.
Kreisl WC; Lyoo CH; McGwier M; Snow J; Jenko KJ; Kimura N; Corona W; Morse CL; Zoghbi SS; Pike VW; McMahon FJ; Turner RS; Innis RB;
Brain; 2013 Jul; 136(Pt 7):2228-38. PubMed ID: 23775979
[TBL] [Abstract][Full Text] [Related]
4. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
[TBL] [Abstract][Full Text] [Related]
5. Cerebral blood flow in mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis.
Zhang H; Wang Y; Lyu D; Li Y; Li W; Wang Q; Li Y; Qin Q; Wang X; Gong M; Jiao H; Liu W; Jia J
Ageing Res Rev; 2021 Nov; 71():101450. PubMed ID: 34419673
[TBL] [Abstract][Full Text] [Related]
6. Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment-dementia converters measured by positron emission tomography with [¹¹C]DAA1106.
Yasuno F; Kosaka J; Ota M; Higuchi M; Ito H; Fujimura Y; Nozaki S; Takahashi S; Mizukami K; Asada T; Suhara T
Psychiatry Res; 2012 Jul; 203(1):67-74. PubMed ID: 22892349
[TBL] [Abstract][Full Text] [Related]
7. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
[TBL] [Abstract][Full Text] [Related]
8. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
Bauckneht M; Chincarini A; Piva R; Arnaldi D; Girtler N; Massa F; Pardini M; Grazzini M; Efeturk H; Pagani M; Sambuceti G; Nobili F; Morbelli S
Alzheimers Res Ther; 2018 Apr; 10(1):35. PubMed ID: 29615111
[TBL] [Abstract][Full Text] [Related]
9. Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease.
Mandal PK; Saharan S; Tripathi M; Murari G
Biol Psychiatry; 2015 Nov; 78(10):702-10. PubMed ID: 26003861
[TBL] [Abstract][Full Text] [Related]
10. The Precuneus - A Witness for Excessive Aβ Gathering in Alzheimer's Disease Pathology.
Aghakhanyan G; Vergallo A; Gennaro M; Mazzarri S; Guidoccio F; Radicchi C; Ceravolo R; Tognoni G; Bonuccelli U; Volterrani D
Neurodegener Dis; 2018; 18(5-6):302-309. PubMed ID: 30814473
[TBL] [Abstract][Full Text] [Related]
11. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
[TBL] [Abstract][Full Text] [Related]
12. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
[TBL] [Abstract][Full Text] [Related]
13. Neuroinflammation in Parkinson's disease: a meta-analysis of PET imaging studies.
Zhang PF; Gao F
J Neurol; 2022 May; 269(5):2304-2314. PubMed ID: 34724571
[TBL] [Abstract][Full Text] [Related]
14. Pittsburgh compound B retention and progression of cognitive status--a meta-analysis.
Chen X; Li M; Wang S; Zhu H; Xiong Y; Liu X
Eur J Neurol; 2014 Aug; 21(8):1060-1067. PubMed ID: 24612390
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment.
Knezevic D; Mizrahi R
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt B):123-131. PubMed ID: 28533150
[TBL] [Abstract][Full Text] [Related]
16. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
[TBL] [Abstract][Full Text] [Related]
17. Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: An update.
Gouilly D; Saint-Aubert L; Ribeiro MJ; Salabert AS; Tauber C; Péran P; Arlicot N; Pariente J; Payoux P
Eur J Neurosci; 2022 Mar; 55(5):1322-1343. PubMed ID: 35083791
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.
Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N
Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054
[TBL] [Abstract][Full Text] [Related]
19. Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease.
Han P; Caselli RJ; Baxter L; Serrano G; Yin J; Beach TG; Reiman EM; Shi J
JAMA Neurol; 2015 Mar; 72(3):333-9. PubMed ID: 25599520
[TBL] [Abstract][Full Text] [Related]
20. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]